Epi Hlth Drug Patent Portfolio
Epi Hlth owns 1 orange book drug protected by 1 US patent Given below is the list of Epi Hlth's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103517 | Pharmaceutical compositions for minocycline | 07 Apr, 2036 | Active |
Latest Legal Activities on Epi Hlth's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Epi Hlth.
| Activity | Date | Patent Number |
|---|---|---|
| ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 31 Aug, 2021 | US11103517 |
|
Recordation of Patent Grant Mailed
Critical
| 31 Aug, 2021 | US11103517 |
|
Email Notification
Critical
| 12 Aug, 2021 | US11103517 |
|
Issue Notification Mailed
Critical
| 11 Aug, 2021 | US11103517 |
|
Application Is Considered Ready for Issue
Critical
| 29 Jul, 2021 | US11103517 |
| Dispatch to FDC | 29 Jul, 2021 | US11103517 |
|
Issue Fee Payment Received
Critical
| 26 Jul, 2021 | US11103517 |
|
Email Notification
Critical
| 26 Jul, 2021 | US11103517 |
| Printer Rush- No mailing | 26 Jul, 2021 | US11103517 |
| Mailing Corrected Notice of Allowability | 26 Jul, 2021 | US11103517 |
|
Issue Fee Payment Verified
Critical
| 26 Jul, 2021 | US11103517 |
| Corrected Notice of Allowability | 20 Jul, 2021 | US11103517 |
|
Mail Notice of Allowance
Critical
| 19 Jul, 2021 | US11103517 |
|
Pubs Case Remand to TC
Critical
| 19 Jul, 2021 | US11103517 |
|
Email Notification
Critical
| 19 Jul, 2021 | US11103517 |
Epi Hlth's Family Patents
Epi Hlth Drug List
Given below is the complete list of Epi Hlth's drugs and the patents protecting them.
1. Minolira
Minolira is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103517 | Pharmaceutical compositions for minocycline |
07 Apr, 2036
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Minolira's drug page